U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 5O.2Sb
Molecular Weight 323.517
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ANTIMONY PENTOXIDE

SMILES

[O--].[O--].[O--].[O--].[O--].[Sb+5].[Sb+5]

InChI

InChIKey=HFDPUERWEDZVAU-UHFFFAOYSA-N
InChI=1S/5O.2Sb/q5*-2;2*+5

HIDE SMILES / InChI

Molecular Formula Sb
Molecular Weight 121.76
Charge 5
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula HO
Molecular Weight 17.0073
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ef48d40-6d63-440b-a73c-46d89f425936

Stibophen (Fuadin), an organic trivalent antimony compound, has been used for many years in the treatment of schistosomiasis. Stibophen is used as treatment of schistosomiasis by intramuscular injection. Stibophen is known to act by selectively inhibiting worm PFK.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q27778
Gene ID: NA
Gene Symbol: PFK
Target Organism: Schistosoma mansoni (Blood fluke)
Conditions
PubMed

PubMed

TitleDatePubMed
Evaluation of fuadin therapy in schistosomiasis japonica.
1951 Apr
Laboratory studies on the joint effects of certain tris (p-aminophenyl) carbonium salts and antimonials as antischistosomal drugs.
1965
Current chemotherapy of schistosomiasis japonica in the Philippines.
1976 Jun
[Substantiation of maximum permissible levels of antimony trioxide and pentasulide in the atmospheric air of inhabitated places].
1989 Apr
Purification, kinetics and inhibition by antimonials of recombinant phosphofructokinase from Schistosoma mansoni.
1996 Oct 30
Antimony impairs nucleotide excision repair: XPA and XPE as potential molecular targets.
2010 Jul 19
Investigation on the pharmacological profile of 2,6-diacetylpyridine bis(benzoylhydrazone) derivatives and their antimony(III) and bismuth(III) complexes.
2012 Jul
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:42:26 UTC 2023
Edited
by admin
on Sat Dec 16 08:42:26 UTC 2023
Record UNII
756OCG058B
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ANTIMONY PENTOXIDE
MI  
Common Name English
ANTIMONY OXIDE (SB2O5)
Common Name English
ANTIMONY(V) OXIDE
Common Name English
ANTIMONY PENTOXIDE [MI]
Common Name English
Code System Code Type Description
CAS
1314-60-9
Created by admin on Sat Dec 16 08:42:26 UTC 2023 , Edited by admin on Sat Dec 16 08:42:26 UTC 2023
PRIMARY
EPA CompTox
DTXSID6050467
Created by admin on Sat Dec 16 08:42:26 UTC 2023 , Edited by admin on Sat Dec 16 08:42:26 UTC 2023
PRIMARY
PUBCHEM
91617939
Created by admin on Sat Dec 16 08:42:26 UTC 2023 , Edited by admin on Sat Dec 16 08:42:26 UTC 2023
PRIMARY
FDA UNII
756OCG058B
Created by admin on Sat Dec 16 08:42:26 UTC 2023 , Edited by admin on Sat Dec 16 08:42:26 UTC 2023
PRIMARY
WIKIPEDIA
Antimony pentoxide
Created by admin on Sat Dec 16 08:42:26 UTC 2023 , Edited by admin on Sat Dec 16 08:42:26 UTC 2023
PRIMARY
MERCK INDEX
m1959
Created by admin on Sat Dec 16 08:42:26 UTC 2023 , Edited by admin on Sat Dec 16 08:42:26 UTC 2023
PRIMARY Merck Index